Spinal interleukin-16 mediates inflammatory pain via promoting glial activation
International Immunopharmacology · 2024
DOI: 10.1016/j.intimp.2023.111411 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Xuan Zhu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi 71006…. Hauptthemen laut MEDLINE: Interleukin-16, Hyperalgesia. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Proinflammatory cytokines are crucial contributors to neuroinflammation in the development of chronic pain. Here, we identified il16, which encodes interleukin-16 (IL-16), as a differentially expressed gene in spinal dorsal horn of a complete Freund's Adjuvant (CFA) inflammatory pain model in mice by RNA sequencing. We further investigated whether and how IL-16 regulates pain transmission in the spinal cord and contributes to the development of inflammatory pain hypersensitivity. RNA sequencing and bioinformatics analysis revealed elevated IL-16 transcript levels in the spinal dorsal horn after CFA injection. This increase was further confirmed by qPCR, immunofluorescence, and western blotting. Knockdown of IL-16 by intrathecal injection of IL-16 siRNA not only attenuated CFA-induced mechanical and thermal pain hypersensitivity, but also inhibited enhanced c-fos expression and glial activation in the spinal dorsal horn in male mice injected with CFA. Moreover, exogenous IL-16 induced nociceptive responses and increased c-fos expression and glial activation in spinal dorsal horn. This effect was largely impaired when CD4, the binding receptor for IL-16, was inhibited. In addition, CD4 expression was upregulated in the spinal dorsal horn after CFA injection and CD4 was present in microglia and in contact with astrocytes and activated spinal neurons. Taken together, these results suggest that enhanced IL-16-CD4 signaling triggers pain and activates microglia and astrocytes in the spinal dorsal horn, thus contributing to inflammatory pain. IL-16 may serve as a promising target for the treatment of inflammatory pain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi 710061, China; Institute of Neuroscience, Translational Medicine Institute,…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhu, X., Liu, S., Tian, L., Li, X., Yao, R., Zhao, Y., Gao, Z., Liu, X. R., Liu, X. Q., Huo, F. Q., & Liang, L. (2024). Spinal interleukin-16 mediates inflammatory pain via promoting glial activation. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.111411
Vancouver
Zhu X, Liu S, Tian L, Li X, Yao R, Zhao Y, et al. Spinal interleukin-16 mediates inflammatory pain via promoting glial activation. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2023.111411
BibTeX
@article{Zhu2024,
author = {Zhu, Xuan and Liu, Siyi and Tian, Lixia and Li, Xiang and Yao, Rongrong and Zhao, Yunhan and Gao, Zihao and Liu, Xue-Ru and Liu, Xin-Qi and Huo, Fu-Quan and Liang, Lingli},
title = {Spinal interleukin-16 mediates inflammatory pain via promoting glial activation},
journal = {International Immunopharmacology},
year = {2024},
doi = {10.1016/j.intimp.2023.111411}
}
EUVIMED